Formulation of Gastric Floating System Using Bio-Sourced Terminalia Catappa Gum and in vivo Evaluation

Author(s): Venkata Srikanth Meka , Venkata Ramana Murthy Kolapalli .

Journal Name: Current Drug Delivery

Volume 13 , Issue 6 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

A central composite design was applied to design a novel gastric floating drug delivery system comprising propranolol HCl in Terminalia catappa gum and to evaluate the buoyancy, in vitro drug release behavior, and pharmacokinetic parameters. All formulations exhibited good buoyancy properties in vitro reflected by floating lag time of 1-110 sec, total floating time of 9-16 h and prolonged release behaviour (upto 12 h). Statistically optimised formulation (PBGRso) was orally administered to human volunteers under both fasted and fed conditions to evaluate gastric floating behavior under different food conditions by X-ray evaluation. In vivo studies of optimised formulations revealed that the gastric residence time of floating tablets was enhanced in the fed but not in the fasted state. Pharmacokinetic studies of the optimised Terminalia catappa formulation and a commercial product (Ciplar LA 80) carried out on healthy human volunteers showed a significant improvement in the bioavailability (132%) of propranolol HCl released from from the experimental Terminalia catappa formulations compared with Ciplar LA 80.

Keywords: Buoyancy, central composite design, floating drug delivery, in vivo studies in humans, propranolol HCl, Terminalia catappa.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 6
Year: 2016
Page: [971 - 981]
Pages: 11
DOI: 10.2174/1567201812666151009115756
Price: $58

Article Metrics

PDF: 20
HTML: 3